Neoplasms, Hematologic Completed Phase 3 Trials for Olanzapine (DB00334)

Also known as: Hematological Neoplasm / Hematological Neoplasms / Hematologic Neoplasm / Hematologic Neoplasms / Haematological neoplasm / Malignant tumor of lymphoid hemopoietic and related tissue (disorder) / Haematological malignancy / Hematological malignancy / Hematologic neoplasm (disorder)

IndicationStatusPhase
DBCOND0056760 (Neoplasms, Hematologic)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02635984Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy RegimensSupportive Care